Table of contents

Ovarian Cancer

• Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer (19 November, 2019)

  Mustafa Zelal Muallem, Jalid Sehouli, Rolf Richter, Aygun Babayeva, Khayal Gasimli, Asya Parashkevova
• External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response (21 November, 2019)

  Pier Carlo Zorzato, Gian Franco Zannoni, Riccardo Tudisco, Tina Pasciuto, Andrea Di Giorgio, Massimo Franchi, Giovanni Scambia, Anna Fagotti
• Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer (10 December, 2019)

  Yong Li, Can Zhang, Rui Ji, Hong Lu, Weiling Zhang, Ling-Ling Li, Rong Liu, Hongyan Qian, Aiqin He
• Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers

  (27 November, 2019)

  Jordi Ponce, Sergi Fernandez-Gonzalez, Iris Calvo, Maite Climent, Judith Peñafiel, Lidia Feliubadaló, Alex Teulé, Conxi Lázaro, Joan Maria Brunet, Beatriz Candás-Estébanez, Montserrat Durán Retamal
• Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors (1 December, 2019)

  Graziela Zibetti Dal Molin, Shannon Neville Westin, Pavlos Msaouel, Larissa M Gomes, Andrea Dickens, Robert L Coleman
• Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas (7 November, 2019)

  Cassandra B Dowson, Colin Stewart, Sarah O'Sullivan, Nicholas Pachter, Lyn Schofield, Paul A Cohen